본문으로 건너뛰기
← 뒤로

Anatomical Sublobar Resection for Multi-Intersegmental Pulmonary Nodules.

1/5 보강
Thoracic cancer 📖 저널 OA 94.2% 2023: 1/1 OA 2025: 14/14 OA 2026: 34/37 OA 2023~2026 2026 Vol.17(3) p. e70216
Retraction 확인
출처

PICO 자동 추출 (휴리스틱, conf 3/4)

유사 논문
P · Population 대상 환자/모집단
93 patients undergoing ASR and 118 subjects undergoing lobectomy were included.
I · Intervention 중재 / 시술
ASR or lobectomy between 2012 and 2023 were retrospectively screened
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
After PSM, 34 matched patients remained in each group, and the RFS was 100% in both groups. [CONCLUSIONS] ASR is feasible for multi-intersegmental nodules and can preserve more pulmonary parenchyma with no compromise in perioperative and oncological outcomes compared to lobectomy.

Pan X, Zhou S, Li Z, Xu W, Chen L, Wu W

📝 환자 설명용 한 줄

[BACKGROUND] Anatomical sublobar resection (ASR) is non-inferior to lobectomy for peripheral small-sized lung cancer.

🔬 핵심 임상 통계 (초록에서 자동 추출 — 원문 검증 권장)
  • p-value p < 0.001
  • 추적기간 32 months

이 논문을 인용하기

↓ .bib ↓ .ris
APA Pan X, Zhou S, et al. (2026). Anatomical Sublobar Resection for Multi-Intersegmental Pulmonary Nodules.. Thoracic cancer, 17(3), e70216. https://doi.org/10.1111/1759-7714.70216
MLA Pan X, et al.. "Anatomical Sublobar Resection for Multi-Intersegmental Pulmonary Nodules.." Thoracic cancer, vol. 17, no. 3, 2026, pp. e70216.
PMID 41607109 ↗

Abstract

[BACKGROUND] Anatomical sublobar resection (ASR) is non-inferior to lobectomy for peripheral small-sized lung cancer. However, for nodules located in complex locations, ASR is usually challenging. This study aimed to compare the outcomes of ASR and lobectomy for multi-intersegmental pulmonary nodules.

[METHODS] Patients with pulmonary nodules (≤ 2 cm) who underwent ASR or lobectomy between 2012 and 2023 were retrospectively screened. The 3D multiplanar reconstruction software was used to determine the precise tumor localization. Demographic, radiomic, histopathologic, and perioperative characteristics between ASR and lobectomy were compared. The log rank test was adopted for prognostic evaluation. Propensity score-matching (PSM) analysis was conducted to yield matched patients.

[RESULTS] In total, 93 patients undergoing ASR and 118 subjects undergoing lobectomy were included. Patients with ASR were younger and had a smaller tumor size, fewer solid nodules, and more central nodules than those with lobectomy. ASR achieved a median surgical margin of 2.0 cm, removed fewer lymph nodes, and preserved seven more subsegments than lobectomy (5 vs. 12, p < 0.001), without increasing air leak or postoperative hospital stay. During a median follow-up of 32 months, four patients in the lobectomy group encountered tumor recurrence, whereas no recurrence occurred in the ASR group. The 5-year recurrence-free survival (RFS) after lobectomy and ASR was 95.4% and 100%, respectively. After PSM, 34 matched patients remained in each group, and the RFS was 100% in both groups.

[CONCLUSIONS] ASR is feasible for multi-intersegmental nodules and can preserve more pulmonary parenchyma with no compromise in perioperative and oncological outcomes compared to lobectomy.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (5)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🟢 PMC 전문 열기